JAZZ vs SFST · P/E 1988, rev $2.28B vs P/E 14, rev $2.8M
Jazz Pharmaceuticals PLC (JAZZ) versus Southern First Bancshares Inc (SFST) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Southern First Bancshares Inc (SFST) is a banks - regional company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SFST revenue for 2026-06-30 was $2.8M. Net income was $21.1M. Revenue was up 88.6% from 2026-03-31 to 2026-06-30. SFST currently screens at market cap $547.9M and trailing P/E 13.6.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SFST currently screens at market cap $547.9M and trailing P/E 13.6.
Not investment advice. Open the JAZZ and SFST stock pages for the full models.
Not investment advice.